Trientine and Carboplatin in Advanced Malignancies
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of the
combination of trientine and carboplatin that can be given to patients with advanced cancer.
The safety of this drug combination will also be studied.